SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (3085)5/27/1999 7:27:00 PM
From: Art Vandelay AIA   of 10280
 
One area many are neglecting is those drugs that couldn't make it all the way to FDA approval. To the extent that SEPR can eliminate side effects or work on dosages, there is another application for SEPR's ICE technology. Amazingly, they are still lightyears ahead of big pharma and competitors in this area, though logic would dictate that JNJ, SGP, and LLY, at a minimumm, would have learned by now. But let's try to keep it quiet for awhile, please, as SEPR is busy building more value. I'm more than happy to wait for notoriety while I accumulate more cash.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News